TITLE

Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient: a complication of cyclophosphamide

AUTHOR(S)

Lienesch, D.W.; Mutasim, D.E.; Singh, R.R.

PUB. DATE

September 2003

SOURCE

Lupus;2003, Vol. 12 Issue 9, p707

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Neutrophilic eccrine hidradenitis (NEH) is an unusual self-limited skin disorder characterized by an inflammatory cell infiltrate in the deep dermis involving the eccrine sweat glands, commonly presenting as painful cutaneous nodules. NEH occurs most frequently in patients receiving chemotherapy for haematologic malignancies. We report a case of NEH masquerading as cutaneous vasculitis in a woman receiving cyclophosphamide for lupus nephritis. The association of NEH and the use of cytotoxic agents for SLE or other autoimmune diseases has not been reported previously. NEH must be considered in lupus patients receiving cytotoxic agents to avoid inappropriate use of corticosteroids or antibiotics in this self-limited condition.

ACCESSION #

10832541

Tags: LUPUS;  SWEAT glands;  VASCULITIS;  LUPUS nephritis;  SKIN

 

Related Articles

• Current treatment of lupus nephritis. Houssiau, F. A.; Ginzler, E. M. // Lupus;2008, Vol. 17 Issue 5, p426 

  This review on the management of lupus nephritis is based on the results of randomized clinical trials, and discusses the principles of treatment and the current options for induction and maintenance therapy. The respective place of mycophenolate mofetil and intravenous cyclophosphamide are...

• Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Fismen, S.; Hedberg, A.; Fenton, K. A.; Jacobsen, S.; Krarup, E.; Kamper, A. L.; Rekvig, O. P.; Mortensen, E. S. // Lupus;Jul2009, Vol. 18 Issue 7, p597 

  Murine and human lupus nephritis are characterized by glomerular deposits of electron-dense structures (EDS). Dominant components of EDS are chromatin fragments and IgG antibodies. Whether glomerular EDS predispose for similar deposits in skin is unknown. We analysed (i) whether dermoepidermal...

• Hypertension and Systemic Disease.  // Kidney;Sep/Oct2003, Vol. 12 Issue 5, p218 

  Presents information on studies about hypertension and systemic disease. Determination of the incidence of recurrent lupus nephritis in renal transplant recipients with systemic lupus erythematosus; Investigation of the association betwe en primary systemic vasculitis and environmental risk...

• Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis. Tanaka, Hiroshi; Tsugawa, Koji; Suzuki, Koichi; Nakahata, Tohru; Ito, Etsuro // Pediatric Nephrology;Jul2006, Vol. 21 Issue 7, p962 

  Mizoribine (MZR) is a novel purine synthesis inhibitor that was developed in Japan. We previously reported the efficacy and safety of oral MZR intermittent pulse therapy, which is associated with elevated peak serum MZR levels, in selected patients with lupus nephritis. However, the efficacy and...

• Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Isenberg, D. A.; Manson, J. J.; Ehrenstein, M. R.; Rahman, A. // Rheumatology;Jul2007, Vol. 46 Issue 7, p1052 

  The year 2007 marks the 50th anniversary of the identification of antibodies to double-stranded (ds) DNA. Whilst widely regarded as synonymous with patients who have systemic lupus erythematosus (SLE), doubts have been raised about their significance and the extent to which they are genuinely...

• Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB � NZWF[sub 1] mice. Hasegawa, K.; Hayashi, T. // Lupus;2003, Vol. 12 Issue 11, p838 

  The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB � NZWF[sub 1] (B/WF[sub 1]) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued...

• Editor�s foreword.  // Lupus;1998, Vol. 7 Issue 9, p573 

  Introduces a series of articles on lupus nephritis which were published in the September 1998 issue of `Lupus.'

• EFFICACY AND SAFETY OF A SHORT-COURSE INTRAVENOUS PULSE CYCLOPHOSPHAMIDE REGIMEN IN PROLIFERATIVE LUPUS NEPHRITIS: INTERIM ANALYSIS OF THE EURO-LUPUS NEPHRITIS TRIAL.  // Lupus;Jan2001 Supplement 1, Vol. 10, pS94 

  The article presents an abstract of the study "Efficacy and Safety of a Short-Course Intravenous Pulse Cyclophosphamide Regimen in Proliferative Lupus Nephritis: Interim Analysis of the Euro-Lupus Nephritis Trial." A randomized study aimed with concerns on its toxicity for patients diagnosed in...

• Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis. Ross, Sophia; Benz, Kerstin; Sauerstein, Katja; Amann, Kerstin; Dtsch, Jrg; Dittrich, Katalin // BMC Nephrology;2012, Vol. 13 Issue 1, p81 

  Background: Severe renal manifestation of systemic lupus erythematosus (SLE) is not uncommon and is associated with an indeterminate prognosis. Complete remission can be obtained, however, at least in the young when chronic lesions are absent and adequate anti-inflammatory therapy is immediately...

Read the Article